Browse All

Current Filters

CLEAR FILTER x

TITLE

Rapid and Sustained Efficacy of Subcutaneously Administered Cemdisiran Without Complete Complement Blockade in Patients with Generalized Myasthenia Gravis (gMG): Primary Efficacy and Safety Results from the Phase Three NIMBLE Trial

Sustained Clinical Efficacy and Long-term Safety of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT

Response to Rozanolixizumab Across Treatment Cycles in Patients With Generalized Myasthenia Gravis: A Post Hoc Analysis of Final Pooled Phase Three Data